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7-Ethyl-octahydro-2-methyl-6H-pyrazino[1,2-c]pyrimidin-6-one· (Centperazine) 1, an anti-filarial
drug, currently undergoing phase 111 clinical trials has been synthesized by a short, practical and
economical route suitable for large scale production. Thus 2-(2-ethylarninoethyl)pyrazine obtained from
2-vinylpyrazine and ethyl amine, on ethoxycarbonylation, catalytic hydrogenation, cyclo carbamation
and N-methylation yields Centperazine 1 in 23.1% overall yield.
7-Ethyl-octahydro-2-methyl-6H-pyrazino[1, 2-c]-
pyrimidin-6-one (Centperazine)' 1, a structural
analog of diethylcarbamazine (DEC), by virtue of
having one of the ethyl groups of DEC "frozen" in
to a cyclic system, exhibits a very high degree of
anti-filarial activity':'. The enhanced pharmaco-
logical activity is attributed to the restricted
conformational mobility" of Centperazine. 1 is in
the phase III clinical trials", and has a great
potential of becoming an anti-filarial drug.
Consequently a safe, economical and practical
synthesis suitable for its manufacture is highly
desirable.
Retro-synthetically 1 can be elaborated from
n-aminoethylpiperazine i (Scheme I). 2 can be
derived by cyclo-condensation of ethylene diamine
with appropriate synthon with a four carbon unit
having a nitrogen-appendage. Alternately 2 can be
derived from 2-(2-amino ethyl)pyrazine.
Based upon former approach Anand et al.3,5,6
had obtained the piperazine 2a from the
piperazinone amide 3. Synthesis of 2a from 3
requires a four fold amount of LAH. Hence a large
scale production of 1 through this route is
uneconomical and requires a great degree of safety
precautions.
We had devised? an alternative synthesis of 1 to'
eliminate the use of LAH in which the piperazine
derivative 2b was obtained from the piperazine
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nitrile 4 by selective catalytic hydrogenation.
Both 3 and 4 were synthesized from N-
benzylated ethylene diamine, in order to moderate
the reactivity of ethylenediamine in the cyclo-
condensation step and hence an additional step was
required for the removal of the protecting group
i.e. debenzylation'' of 2a or conversion" of 2b to 2c.
In order to eliminate these drawbacks a short
and practical synthesis of 1, suitable for large scale
production starting from 2-(2-amino ethyl)pyrazine
is herewith disclosed (Scheme II)S. 2-
Vinylpyrazine 5 readily prepared from 2-
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methylpyrazine in 2 steps as reported in the lit.", on
condensation with aqueous ethyl amine furnished
2-( ethyl amino ethyl)pyrazine 6. Treatment of 6
with ethyl chloroformate furnished the pyrazine
carbamate 7. The reduction of 7 to piperazine 8
could be accomplished by Rh/C (5%) catalyzed
hydrogenation in methanolic hydrochloric acid in
place of the customarily used Adam's catalyst i.e.
Pt02 in acetic acid'':'" and economy in the process
is achieved. On treatment with sodium methoxide,
the carbamate 8 smoothly cyclised to the bicyclic
octahydro-6H-pyrazino[ 1,2-c [pyrimidin-e-one 9.
As 8 has two nucleophilic nitrogen atoms can
cyclise to furnish 9 or 10. The shift of carbonyl
absorption in the IR spectra of of 8 from 1700 em"
in the IR spectra of 9 indicate cyclisation of 8 to 9
possessing a cyclic ureide bond. The PMR spectra
of 8 shows signal due to C2-H between 8 2.68 and
2.78. The corresponding CIO-H in 9 resonates at 8
4.34. The 1.58 ppm downfield shift of methine
proton at the ring junction. (CIO-H) conclusively
proved the formation of 6-hexahydropyrimidinone
9 instead of 10. The shift can only be due to
anisotropic de shielding effect of the Co=O of 9.
The formation of 1,4,6-triazabiclo[ 4.3.1 ]nonan-5-
one 10 is precluded as such a downfield shift of
10
Scheme n
CIO-H signal would not have resulted by it's
formation due to less proximity of C=O to methine
proton at ring junction in 10. Treatment of 9 with
HCHOIHC02H affords 1 in 70% yield.
Due to low volatility of the intermediates
encountered in earlier synthesis':", their
purification demands ultra high vacuum distillation
or column chromatography. In contrast the
pyrazines 5, 6, 7 and piperazine 8 could be distilled
at moderate vacuum (1-20 torr) and hence easier
purification could be achieved on a large scale.
Furthermore formation of any side product at
higher scale of preparation in any of the steps was
not encountered. Thus a practical synthesis of 1 in
23.1 % overall yield in five steps is accomplished II.
Experimental Section
IR spectra were recorded with a Perkin-Elmer
157 spectrometer (Amax in cm'), IH NMR with a
Perkin-Elmer R-32 (90 MHz) and a Bruker wm
400 MHZ) spectrometer using TMS as an internal
standard (chemical shift in 8 values) and mass
spectra on a Jeol 0-300 spectrometer. Elemental
analysis were determined by a Carlo Era 1108
machine.
SAHU: SYNTHESIS OF CENTPERAZINE 1151
2-Vinylpyrazine 5 was prepared as per the
literature procedure" starting from 2-
methylpyrazine, yield: 46%; b.p. 58-60°C/30 torr.
IR (neat) 1610. PMR (CCI4): 5.52 (dd, 1H, 1.5 Hz,
10 Hz); 6.20 (dd, 1H, 1.5 Hz, 14 Hz); 6.8 (dd, 1H,
10 Hz, 14 Hz); 8.25 (m, 3H).
2-(2-(N-Ethyl)amino)pyrazine 6. To a solution
of 5 (6.36 g, 0.06 mol) and aq. ethyl amine (9 mL,
70%) in methanol (60 mL), gl. acetic acid (0.5 mL)
was added and the mixture was heated at 60°C for
24 hr. The reaction product was cooled to room
temperature and evaporated in vacuo. The residual
liquid was made basic with aq. NaOH and
extracted with ethyl acetate (3x30 mL). The
combined ethyl acetate extracts was washed with
brine, dried over anhyd. sodium sulfate, filtered
and evaporated. The residual liquid was
fractionated in vacuo to yield 8.19 g, b.p. 115-
120°C/3 torr; IR: 3300-3600, 1610. NMR (CDCI3):
1.25 (t, 3H); 2.6 (bs, IH, exchangeable with DP);
3.20 (m, 4H); 3.45 (q, 2H); 8.15 (m, 3H). Analysis:
CgH13N3 requires C: 63.5; H, 8.60; N, 23.87.
Found: C: 63.21; H: 8.45; N: 23.78%.
2-(2-(N-Carboethoxyethyl)amino ethyl)pyra-
zine 7. To a solution of 2-(2-ethylamino)-
ethylpyrazine 6 (6.04 g, 40 mmoles) and
triethylamine (7 mL, 50 mmoles) in toluene (60
mL), ethyl chloroformate (4.6 mL, 42 mmoles)
was added drop-wise with stirring at 5-1O°C. The
mixture was stirred at room temp. for 30 min and
heated to reflux for 1 hr. The reaction mixture was
cooled to ambient temp., washed with water, dried
(anhyd. Na1S04) and filtered. The filtrate was
concentrated in vacuo. The residual liquid was
distilled in vacuum to give 6.96 g of liquid product
boiling at 150-54°C/5 torr (132-5°C/3.5 torr). IR
(neat): 3300-3600 (N-H stretching); 2950 (C-H
stretching); 1680 (C=O). PMR: (CDCI3): 1.25 (t,
3H, 9 Hz); 1.4 (t, 3H, 9 Hz); 3.25 (t, 2H, 7 Hz);
3.35 (t, 2H, 7 Hz); 3.6 (q, 2H); 4.05 (q, 2H); 8.10
(m, 3H). Mass (12 eV): mlz: 223 (M+, 68%).
Analysis: 'C"H17N101 requires C: 59.19; H: 12.82;
N: 18.63. Found C: 59.4; H: 12.58; N: 18.63%.
2- (2-N-Carboethoxyethyl) amino ethyl) pipe-
azine 8. To a solution of 6 (4.5 g, 20.17 mmoles)
in methanol (60 mL) methanolic hydrochloric acid
(10%, 15 mL) was added under cooling followed
by addition of Rhodium on carbon catalyst (0.3 g,
5%). The mixture was hydrogenated at 150 psi
between 40-50°C for a period of 6 hr. The catalyst
was made neutral with 4 N aq. NaOH solution and
evaporated in vacuo. The residual liquid was
extracte~ with ethyl acetate (3x30 mL). The
combined ethyl acetate extract as washed with
satd. brine, dried over anhyd. Na2S04 evaporated
and finally distilled in vacuo to afford 3.23 g
(70%) of8, b.p. 135-138°CI2 torr. IR (neat): 3300-
3600 (N-H stretch); 2950-2970 (C-H stretch); 1680
(C=O). NMR (CDCI3, 60 MHz): 1.05 (t, 3H); 1.2'
(t, 3H); 2.12 (m, 2H);2.7-3.6 (m, 11H) 5.2 (bs,
I .
IH), eX1hangea~le with D2); ~.35 (bs, 1H,
exchangeable WIth D20).AnalysIs: CIlH23N302
(229) requires C: 57.64; H: 10.09; N: 18.34. Found
C: 57.35;}{: 9.88; N: 17.96%.
7-Ethyl-octahydro-6H-pyrazino [1,2-c] pyrl-
midin-6-one 9. To a solution of 8 (4.12 g, 18
mmoles) in anhyd. ethanol (30 mL) was added
sodium ethoxide (0.51 g, 7.5 mmoles). The
mixture was heated to reflux with stirring under
anhyd. condition for 24 hr and evaporated to
dryness. The residual liquid was dissolved in ethyl
acetate (30 mL) and washed with water, satd.
brine, dried (anhyd. Na2S04), evaporated and
distilled in vacuo to yield 2.28 g of 9 (68%); b.p.
130-35°CIl torr; hydrochloride m.p.: 212-5°C. IR
(neat): 3500-3100 (N-H stretch); 2950 (C-
Hstrech), 1650 (N-(C=O)-N). PMR (400 MHz
CDCI3): 1.05-1.15 (t, 3H, piperazinyl 7-CH2CH3);
1.68-1.92 (m, 2H, piperazinyl-Slf); 2.28-2.70 (s,
IH, N-H); 2.80-3.00 (m, 4H: pierazinyl H); 3.08-
3.2 (q, 2H, piperazinyl 7-CH1CH3); 3.20-3.32 (m,
4H, piperazinyl H); 4.25-4.32 (m, IH, piperazinyl
10-H) cf. ref.'. Mass (70 eV): 183 (M+, 20%).
Analysis: Calc. C: 59.01; H: 9.25; N: 22.95.
Found: C: 58.79; H: 9.35; N: 22.58%.
7 - Ethyl - octahydro - 2-methyl - 6H -pyra-
zino- [1, 2-c] pyrimin-6-one 1. To a solution of 9
(2.25 g, 13.66 mmoles) in formic acid (4.5 mL,
98%), formaldehyde solution (40%, 15 mL) was
added and the mixture was heated at 80°C for 6 hr.
Excess formic acid and formaldehyde were
removed under reduced pressure. The residual
liquid was basified to pH 10 with aq. NaOH
solution (4 N) and was extracted with ethyl acetate
(3x20 mL). The combined organic extract was
evaporated to yield an oily product which was
purified by filtration through a bed of basic
alumina using ethyl acetate as eluent, yield 1.89 g
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(70%). IR (Neat): 3300-3100 (N-C2Hs, N-CH3' 4
stretch); 3020 (C-H, stretch), 1655 (C=O) (cf. 4). 5
PMR (400 MHz, CDCI3): 1.08-1.12 (t, 3H, N7-
CH2CH3), 1.70-1.80 (m, 2H, C9-H2), 2.30-2.32 (s, 6
3H: piperazinyl N2-CH3), 3.04-3.10 (m, 2H, N-
CH2CH3), 3.18-3.38 (m, 8H, CI-H2, C3-H2, C.-H2'
Cg-H2), 4.28-4.34 (m, m, Cto-H). MS (70 eV) rnJz
(%): 197 (24), 140 (25), 127 (98). Analysis:
Calculated C: 60.88; H: 9.71; N: 21.0. Found: C:
60.15; H: 9.35; N: 20.93%.
References
1 Durg of thefuture, 5, 1980,229.
2 Saxena R, Iyer R N, Anand N, Chatterjee R K & Sen A B,
Jpharm Pharmacal, 22, 1970, 306.
3 Saxena 'R, Sharma S, Iyer R N & Anand N, J mednl
Chem, 14, 1971,929.
Anand N, Indian Natl Sci Acad, Part A, 49, 1983, 233.
.Sharma S, Bindra R, Iyer R N & Anand N, J mednl Chem,
18,1975,913.
Anand N, Chatterjee R K, Iyer R N, Saxena R & Sen A B,
Brit Pat No. 1,284,582 (1971); Chem Abstr, 77, 1972,
152226f; US Pat No. 3,560,503; Chem Abstr, 74, 1971,
1418454.
7 Sengupta S, Sahu D P & Chatterjee S K, Liebig's Ann
Chern, 1993, 437; Drugs of the future, 19, 1994, 437;
Indian Patent Appl 1581DeV92.
8 Kamal M R, Neubert M & Levine R, J org Chem, 27,
1962,1363.
9 Chambers R D, Mnograve W K R, Urben P G, J Chem Sac
Perkin I, 1974, 2584.
10 Bjork A K K, Kjeuberg B E S, Abramo A L & Hemestan
S E H, Brit Pat No. 200,3874; Chem Abstr, 90, 204134q.
11 Sahu D P, Kulangiappar K, Sengupta S, Satyanarayan K V
& Singh C M, Indian Patent Appl. NF/ltl0/93.
